Authors


By Lynda Charters; Reviewed by Carlyn V. Kouwenberg

Latest:

Looking past the eye in paediatric noninfectious uveitis

Disease manifestations in the systemic microcirculation of children


By Hattie Hayes; Reviewed by by Vinita Rangroo Thrane, MD, PhD; Alexander S. Thrane, MD, PhD, FEBOphth; and Nils-Erik Boonstra, MD

Latest:

The true costs of treating paediatric cataracts

A retrospective analysis illuminates discrepancies between adult and paediatric cataract procedures around the globe


Abdelwahhab Azzawi, MD

Latest:

Understanding Schlemm canal to improve the results of stent surgery

Examining the anatomy and physiology may prevent ineffective stent implantation.


David Hutton; Reviewed by Kamran M Riaz, MD

Latest:

Cutting-edge advances in corneal treatment

Surgeon discusses latest trends for treating cornea




Dr David Lally

Latest:

Sustained-release anti-inflammatory therapy proves valuable in NIU

Long-term treatment helps chronic, vision-threatening disease.


By Lynda Charters; Reviewed by Carolina Picotti, MD

Latest:

Treating anisometropic amblyopia with a dichoptic digital platform

The investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age



Prof. Alastair Denniston

Latest:

Insights into the future of eye care

A UK health data research hub containing vast numbers of fundus and OCT images opens the door to improved screening and diagnoses of eye diseases and even ‘oculomic’ services for systemic health.


Dr Monica Lövestam-Adrian

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Hattie Hayes

Latest:

US FDA issues Complete Response Letter for avacincaptad pegol (Izervay, Astellas Pharma Inc)

The CRL comes in response to a supplemental New Drug Application for Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration



James S Talks

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Zeba A. Syed

Latest:

Pearls for management of Pseudomonas scleritis

Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis


Dr Rajen U. Desai

Latest:

New goniotomy device + careful post-op care limits intraoperative bleeding

A new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.


Dr Ramin Tadayoni

Latest:

Worldwide pathological myopia discussed by panel at EURETINA 2021

Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.


Dr Maximilian K. Köppe
Dr Maximilian K. Köppe

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

Newly developed acrylic implant provides option for patients with endothelial dysfunction.



Dr Marguerite B. McDonald

Latest:

New options are on the horizon for presbyopia-correcting drops

For ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.


Bela Parekh, BA, BS; Imane Tarib, MD; and Richard Awdeh, MD

Latest:

Harnessing digital media for enhanced patient engagement and outcomes

Patients who received digital education demonstrated a better understanding of their disease and its management


Dr Sara Giammaria

Latest:

Using pivotal study data to guide glaucoma patient management decisions

Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.


Ms Faiza Bhombal

Latest:

Digital visual training helps treat disorders associated with close work

Computer software platform provides home vision exercises to overcome asthenopia.


By Lynda Charters; Reviewed by Ursula Schmidt-Erfurth, MD

Latest:

Zooming in on geographic atrophy with OCT-based AI

New analysis brings disease progression and therapeutics into focus


By Lynda Charters; reviewed by Giovanni Montesano, MD

Latest:

Six-year findings from laser in glaucoma and ocular hypertension (LiGHT)

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma




Adam M. Katz, MD

Latest:

Letter to the Editor: Intravitreal injections. Who should perform them?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.



Dr Claudia Priglinger

Latest:

First-ever retinal gene therapy: Does real-world experience back its use?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.

© 2024 MJH Life Sciences

All rights reserved.